Since 2019, Apple has released a more affordable standard iPhone and a higher-end "Pro" variant, giving customers multiple flagship iPhones to choose from. Apple is deviating from its standard release ...
CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company’s lead development candidate is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results